Home Study Webinar
Free Activity – available through December 30, 2022.
This home study will provide an overview of the enhanced drug distribution security requirements that will go into effect in 2023. Presenters from Food and Drug Administration (FDA) will discuss updates about important guidance recently published regarding supply chain security requirements and changes for pharmacies in 2023 and beyond. Specifically, the presenters will:
- Review four industry guidance documents that describe proposed and final agency recommendations related to the requirements under the Drug Supply Chain Security Act (DSCSA).
- Discuss enhanced drug distribution security requirements that will go into effect in November 2023.
- Provide examples to help pharmacists understand enhanced product tracing and verification requirements.
This home study webinar is a recording of the live activity that was held on December 15, 2021.
How to Access the Webinar and Earn CPE
The complimentary webinar is eligible for Accreditation Council for Pharmacy Education (ACPE)-accredited continuing pharmacy education (CPE) credit. More details regarding the presentations, CPE activity credits, and browser requirements can be found in the CPE Activity Information guide .
Follow the steps below to access the home study webinar and claim CPE credit:
- Complete the interest form for the desired home study.
- Check your email to get the access code for the requested home study.
Log in to
NABP’s CPE Submission Site
and select the “Home Study CPE” tab.
- If you do not have a log in for Learner Community, you will need to create an account.
Enter the access code provided in your email and click “Redeem Code.”
- Enter only one code at a time.
- View the recording, complete the activity in its entirety, including watching the full video, and pass the post-test. Once completed, the Credit section will unlock.
- Select the appropriate credit (pharmacy or pharmacy technician), enter your NABP e-Profile ID and date of birth, and click the “claim” button to earn credit.
Claims must be submitted within 60 days from the date you opened the activity.
Dr Jung is currently senior advisor for Policy in the Office of Drug Security, Integrity, and Response (ODSIR) in the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), Office of Compliance (OC). Her work focuses on the development of policy and regulatory strategies to improve the security and integrity of the United States drug supply to protect patients from counterfeit or stolen product. She received her bachelor of science degree in pharmacy from The Ohio State University and her doctorate degree in pharmaceutical sciences from the University of Cincinnati. Dr Jung joined FDA in 1999 as a toxicology researcher in the Center for Food Safety and Applied Nutrition, and later served as a Regulatory Reviewer of bioequivalence studies in the Office of Generic Drug before working on supply chain issues.
Abha Kundi is a regulatory counsel in the ODSIR in FDA’s CDER, OC. During her 10 years with FDA, Abha’s work has primarily focused on the development of policy and regulatory strategies to improve the security and integrity of the US drug supply. Abha received both her law degree and master’s degree in public health from Boston University.
Home Study Registration
Complete the form to receive an enrollment code for the Home Study Program(s). You will need to log in to NABP’s CPE Submission Site and enter the enrollment code to view the webinar and earn credit.